Suzhou Industrial Park

Home page > category report > Industries & Enterprises


Innovent Biologics listed at HKEX


Date:   |   Source:       Font Size:    A   A   A

Innovent Biologics, a biotech unicorn based in SIP, made a strong debut at Hong Kong Exchanges and Clearing Market (HKEX) on Oct 31, raising about HK$ 3.155 billion through the sale of 236 million shares at HK$ 13.98.

Founded in 2011, Innovent Biologics has developed into a top developer of low-cost and high-effect biologic drugs in the country, boasting a pipeline of 17 innovative drugs with an emphasis on oncology as well as great contributions to a host of national medical research programs.

The company disclosed that 65% of the raised fund will be used for development of four of its core products, 25% for on-going and planned clinical trials of its drug candidates and 10% for business operation and general corporate purposes.


October 3, 2018